View on Demand
Click here to view this webinar on demand.
Healthcare reform included a number of significant provisions pertaining to the 340B Program. While new entities are now eligible to enroll, there are important legal and regulatory considerations associated with structuring and documenting 340B drug arrangements. This webinar will cover key compliance issues and operational challenges with regard to these arrangements. In addition, the presentation will address recent enforcement trends and guidance from the Health Resources & Services Administration (HRSA), the agency charged with oversight of the 340B Program.